Company intelligence
Intertek Melbourn
Pharmaceutical analysis & formulation contract services. Specialist expertise in inhalation & nasal drug development
About Intertek Melbourn
A leading provider of pharmaceutical analysis and formulation support with 30+ years of experience in inhaled product development and Good Manufacturing Practice (GMP) compliant analytical testing and stability storage services. We have a reputation for providing outstanding and responsive customer service. Previously known as Melbourn Scientific Ltd, the laboratory, based near Cambridge UK, was acquired by Intertek in 2013. We opened a second facility in 2015 and another in 2019 leading to further expansion which has doubled our laboratory footprint. We have specialist skills and experience in analytical testing and formulation for inhaled and intranasal products as well as all other dosage forms for healthcare products. Clients include major pharmaceutical companies, drug delivery innovators, consultants and virtual companies. We have invested continually in the latest equipment and provides a range of services; pre-formulation and formulation, analytical support, method development and validation; stability studies and storage and accelerated feasibility studies. The laboratory is inspected and approved by the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for GMP compliance. The Laboratory has also been inspected by the US Food and Drug Administration (FDA) against GMP as part of clients’ pre-approval inspections. Pharmaceutical Analytical Services Early Stage Pre-formulation support Formulation Development Orally Inhaled Product Development Inhalation Product Analysis And Testing Nasal Drug Product Development Analytical Method Development Method Validation Stability Storage and Testing Dissolution Testing Particle and Drop Characterization and Sizing Product Characterization Chemicals, Manufacturing and Controls (CMC) Support Clinical Trial GMP Manufacture QC Testing
Verified activity
Signals from Intertek Melbourn
9 published signals
Presence & Recognition
Intertek Melbourn Principle Scientists Stacey Crane, Martin Westcott and Sam Clarke are attending the International Conference on Inhalation Drug Delivery in Parma to discuss emerging research, development challenges, and opportunities for innovation.
Reported by Intertek Melbourn
Presence & Recognition
Intertek Melbourn employee Andrea Cusack presented Technological Advances Bridging the Gap for Patients, Clinicians, and Industry Using AI Moderated Interviews at the 5th Annual Inhaled & Nasal Biologics | DNA Forum on 24–25 September 2026 at Hinxton Hall, Cambridge, UK.
Reported by Intertek Melbourn
Presence & Recognition
Intertek Melbourn attended the PharmSci2026 event hosted by the Academy of Pharmaceutical Sciences.
Reported by Intertek Melbourn